Enfusion, Inc. (NYSE:ENFN) Stock Holdings Lessened by Scalar Gauge Management LLC

Scalar Gauge Management LLC cut its stake in shares of Enfusion, Inc. (NYSE:ENFN) by 26.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 453,513 shares of the company’s stock after selling 160,000 shares during the quarter. Enfusion accounts for 2.3% of Scalar Gauge Management LLC’s portfolio, making the stock its 13th largest holding. Scalar Gauge Management LLC’s holdings in Enfusion were worth $4,304,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Dimensional Fund Advisors LP boosted its position in shares of Enfusion by 57.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company’s stock valued at $4,466,000 after purchasing an additional 191,436 shares during the period. Impax Asset Management Group plc boosted its holdings in shares of Enfusion by 25.4% in the third quarter. Impax Asset Management Group plc now owns 676,948 shares of the company’s stock worth $6,424,000 after buying an additional 136,948 shares during the period. SG Americas Securities LLC purchased a new position in shares of Enfusion in the third quarter worth approximately $892,000. PDT Partners LLC purchased a new position in shares of Enfusion in the third quarter worth approximately $867,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Enfusion in the 2nd quarter valued at approximately $683,000. 81.05% of the stock is owned by institutional investors and hedge funds.

Enfusion Stock Performance

NYSE ENFN opened at $9.94 on Friday. The firm’s 50 day moving average price is $9.32 and its two-hundred day moving average price is $8.89. Enfusion, Inc. has a twelve month low of $7.52 and a twelve month high of $10.45. The stock has a market cap of $1.28 billion, a price-to-earnings ratio of 248.56, a PEG ratio of 3.75 and a beta of 0.93.

Enfusion Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.